Jul 27, 2017
F. Hoffmann-La Roche Announces Half Year Results 2017
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| Chairman & CEO: | Osamu Nagayama |
| Inquiries to: | Masahiko Uchida, |
| General Manager, Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0881 |
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its half year results 2017 (January 1 – June 30, 2017).
Roche owns 59.89% of Chugai's outstanding shares (61.32% of the total number of shares issued excluding treasury stock) as of end of June 2017.
Its press release and presentation materials can be found on its website (http://www.roche.com).
Chugai’s performance for the period of January 1 to June 30, 2017 is included in the announced Roche Group’s results.
| Media Releases | Investor Updates | Presentation | Half-Year Report 2017 |
